Cadrenal Therapeutics, Inc. Common Stock (CVKD) Insider Trading
Over the last 3 months, CVKD insiders made 0 open-market buys and 6 sales, a net sale of -$79K (SEC Form 4). Over the last 6 months, 2 institutions increased and 5 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
6
Net (3m)
-$79.2K
Insider trades by month Buys Sells
Aug
Sep
Oct
Dec
May
Jun
Context3-month price -46.1%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 2, 2026 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 303 | $5.01 |
| Jun 2, 2026 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 349 | $4.46 |
| May 29, 2026 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 3,298 | $5.28 |
| May 29, 2026 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 2,989 | $4.93 |
| May 29, 2026 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 6,476 | $5.76 |
| May 26, 2026 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 1,165 | $5.69 |
| Dec 31, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 9,933 | $6.97 |
| Dec 3, 2025 | Golden Lee Scottdirector | Grant | 5,000 | $8.27 |
| Oct 28, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 1,129 | $14.03 |
| Oct 28, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 1,315 | $13.99 |
| Oct 28, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 1,800 | $13.99 |
| Oct 14, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 1,800 | $14.07 |
| Oct 14, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 1,800 | $14.02 |
| Oct 14, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 1,693 | $13.99 |
| Oct 7, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 107 | $13.99 |
| Oct 3, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 500 | $14.13 |
| Oct 1, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 100 | $14.00 |
| Oct 1, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 1,700 | $13.99 |
| Oct 1, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 419 | $14.01 |
| Oct 1, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 881 | $14.01 |
| Sep 26, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 1,500 | $14.00 |
| Sep 26, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 10,900 | $14.05 |
| Sep 26, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 2,581 | $13.99 |
| Sep 26, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 6,790 | $14.09 |
| Aug 29, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 1,193 | $13.99 |
| Aug 29, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Sell | 3,836 | $13.99 |
| Aug 29, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 400 | $14.00 |
| Aug 29, 2025 | Szot Matthew Kofficer: Chief Financial Officer | Sell | 1,600 | $13.99 |
| Mar 24, 2025 | Pham Quang Xdirector, 10 percent owner, officer: CEO and Chairman | Grant | 65,000 | $19.79 |
| Feb 6, 2025 | Ferguson James J. IIIofficer: Chief Medical Officer | Grant | 60,000 | $19.75 |
Source: CVKD SEC Form 4 filings, latest Jun 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their CVKD positions over the last 6 months (SEC Form 13F).
Increased
2
New positions
5
Reduced
5
Sold out
5
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 45K | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 22K | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 8K | May 8, 2026 |
| JPMORGAN CHASE & CO | Unchanged | 8K | May 13, 2026 |
| BLACKROCK, INC. | Increased | 5K | May 13, 2026 |
| Cygnus Capital Advisors, LLC | New Position | 1K | May 13, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 393 | May 15, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Reduced | 300 | May 15, 2026 |
| DESTINY WEALTH PARTNERS, LLC | New Position | 200 | May 11, 2026 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | Reduced | 150 | May 14, 2026 |
| MORGAN STANLEY | Reduced | 100 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 99 | May 11, 2026 |
| ARCHER INVESTMENT CORP | Unchanged | 35 | May 4, 2026 |
| IFP ADVISORS, INC | Unchanged | 30 | Apr 13, 2026 |
| UBS GROUP AG | Reduced | 3 | May 5, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.